Regular physical exercise (PE) leads to a systemic adaptation to redox homeostasis perturbation, one of the hallmarks of exercise adaptation. Studies have shown that PE can alter the molecular composition of extracellular vesicles (EVs), impacting their ability to communicate with other cells and modulate physiological processes. EVs circulating in the body and secreted from various cell types, including skeletal muscle cells, contain various regulatory molecules and mediate intercellular communications and tissue cross-talk. Considering that the health-related benefits of a physically active lifestyle are partially driven by various bioactive molecules released into the circulation during exercise, collectively termed “exerkines”, there has been a rapidly growing interest in the role of EVs cargo as “carriers” in the multi-systemic, adaptive response to exercise. Indeed, a potential mechanism by which plasma EVs released during exercise impact ageing and diseases related to redox impairment is increased delivery of redox components, such as redox transcription factors and antioxidants. This presentation will offer a general overview of the biology of exercise-induced EVs and their putative role in health maintenance and disease prevention, with a focus on redox homeostasis control.  

Friedreich's ataxia (FRDA) (OMIM #229300, ORPHA95) is a rare hereditary disease with a prevalence of 1/20,000 to 1/50,000 in the European population. It is classified as a hereditary peripheral neuropathy of a sensory type, with autosomal recessive inheritance. This disease is caused by the deficiency of a mitochondrial protein called frataxin. Lack of expression of this protein produces accumulation of iron, alterations in the biogenesis of iron-sulfur clusters, failures in complexes I, II and III of the respiratory chain and in the activity of the aconitase enzyme, and a reduction in the biosynthesis of the heme groups. As a consequence, finally, an overload of ROS derived from the Fenton reaction occurs. Together with the movement impairment, 60% of FRDA patients suffer cardiomyopathy, which is the most common cause of death in these patients and has no clear explanation of its physiopathological cause. Two iPSC cell lines from FRDA patients with cardiomyopathy) and a control line were differentiated to ventricular cardiomyocytes in our lab.  Both FRDA cell lines showed changes in heartbeat parameters, such as heart rate and amplitude when compared to the control cell line. Also, calcium homeostasis measured by immunofluorescence showed important differences when compared to the control cell line. RT-PCR analyses of miRNAs related to myocardial function also showed clear differences, especially for miR-323-3p and miR-142-3p. Using EM, we found differences in the mitochondrial size, shape and in mitochondrial cristae organization. These results also correlate with changes in the cardiomyocytes cytoskeleton and in the structure of the sarcomeres using confocal microscopy techniques. Our results showed the correlation between mitochondrial changes and the impairment in ventricular cardiomyocytes activity derived from FRDA’s iPS cells.

Vitamin E (alpha-tocopherol, VE) is essential to prevent severe neurological symptoms and even death of a genetic form of ataxia associated with vitamin deficiency or AVED. Its essentiality is also proven in secondary deficiencies associated with malnutrition and/or malabsorption syndromes that besides moderate to severe neurological abnormalities can contribute to induce metabolic, musculoskeletal, hematological, and immune dysfunctions, especially in the elderly. VE is the most abundant and ubiquitous fat-soluble nutrient with hydrogen atom donating properties (often described as “antioxidant”) of the plasmalemma; its relative abundance with respect to phospholipid residues is by far the highest among other H donors and its membrane levels influence the flux of lipoperoxyl radicals during both enzymatic and non-enzymatic processes of lipid peroxidation. Consequently, VE directly affects the metabolism and function of membrane fatty acids, also playing a key role in lipid signaling and thus in the indirect control of different enzymes, signal transduction, and transcriptional proteins that connect, under a functional point of view, the VE levels in human tissues with many pathophysiological aspects and deficiency symptoms. Recent evidence strongly supports the participation of the long-chain metabolites of VE in at least some of its “non-antioxidant” properties. Altogether these aspects depict the biological complexity of this vitamin which is far from being comprehensively understood. Last-generation omics technologies make it possible to face such a complexity to represent with unprecedented efficacy both the essentiality aspects and the health-promoting potential of this vitamin in human nutrition studies and clinical trials on deficiency syndromes and other human diseases that may benefit from its biological properties. Transcriptomics and especially metabolomics protocols have been utilized in our laboratories, either separate or in multiomics mode, to develop personalized and precision nutrition (i.e. nutrigenomics) platforms of investigation dedicated to this vitamin, and examples of their potential for innovation in VE research will be given in this presentation, including in vitro studies and clinical trials on hepatic fatty acid metabolism and lipotoxicity, the etiologic factor of non-alcoholic fatty liver disease, and studies in kidney disease patients that develop secondary VE deficiency in the context of severe oxidative stress and lipid peroxidation symptoms.

The in vivo determination of oxidative stress always remains a great challenge. Our approach in Liège CHU consists of simultaneously measuring in blood samples four different kinds of biomarkers: enzymatic and non-enzymatic antioxidants, trace elements, markers of oxidative damage to lipids, and identification of sources leading to increased reactive oxygen species (ROS) production. All these biomarkers (n = 16) have been investigated in patients: 1) with Abdominal Aortic Aneurysm (AAA)¹ or operated for Thoracic Abdominal Dissection (TAD)², 2) suffering from Chronic Obstructive Pulmonary Disease (COPD)³ or FacioScapuloHumeral Myopathy (FSHM)⁴, 3) with COVID-19^5,6 and 4) with delirium⁷. When compared to our internal reference values, depletion in non-enzymatic antioxidants (vitamin C, β-carotene, vitamin C/vitamin E ratio, thiol proteins) and trace elements (zinc, selenium) was observed in the majority of these pathologies. By contrast, increased levels in glutathione peroxidase, copper/zinc ratio, lipid peroxides (ROOH), and myeloperoxidase are common in all these diseases.

Ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation, is linked to neurodegenerative disorders and cold-induced cell death. SLC7A11 (xCT) plays a crucial role in protecting cells against ferroptosis by maintaining intracellular cysteine and glutathione levels. SLC7A11 requires the chaperone protein SLC3A2 for its localization on the plasma membrane to mediate cystine uptake. Arctic ground squirrels (AGS) are known to be protected from cold tissue temperatures and oxidative stress and to resist neuropathology following cerebral ischemia/reperfusion. This study investigated how ferroptosis is influenced by the hibernation season in AGS hippocampus. RNA-Seq, gene expression, and differential gene expression analysis were conducted on hippocampus tissue samples from male and female AGS collected during the summer active season, torpor, and interbout arousal (IBA). Hippocampus was dissected from partially thawed whole brain prior to RNA extraction.  Total RNA samples were used for cDNA library construction and sequencing by BGI Americas Corporation (Cambridge, MA) and analyzed using CLC Genomics Workbench (QIAGEN). Genes were mapped to the Ictidomys tridecemlineatus reference genome and transcript (HiC_Itri_2, GCF_016881025.1). Results show the highest number of differentially expressed genes (4,042) in torpor compared to summer active animals. Notably, SLC7A11 expression was elevated in torpor compared to summer active animals (fold change: 1.80, FDR-p value: 0.0034). Additionally, SLC3A2 was significantly upregulated in torpor compared to IBA (fold change: 1.24; FDR-p value: 0.030). SLC7A11 transports glutamate(out)/cystine(in). Cystine is rapidly converted into cysteine, a limiting reactant for glutathione synthesis, in the presence of NADPH. These findings suggest that SLC7A11 and SLC3A2 may protect AGS from ferroptosis during the hibernation season. This research provides insights into the molecular mechanisms underlying neuroprotection in hibernating AGS and may have implications for understanding and potentially treating neurodegenerative disorders.

Dysregulation of the redox system and the interconnected low-level inflammation (LLI) act as a driving force of damaging mechanisms in gestational diabetes mellitus (GDM) and are strongly related to severe obstetric and neonatal complications of hyperglycaemic pregnancies. Major disturbances in microRNA-based mechanism accompany (glyco)oxidative stress ((g)OS), for which reason we hypothesized that microRNAs may serve as sensors and/or effectors of (g)OS/LLI in GDM and we chose candidates for GDM biomarker analysis among known (g)OS/LLI-associated microRNAs. The aim of the study was to analyze the properties of miR-146a-5p and miR-21-5p as redox status indicators in GDM, as well as to compare two different biological samples as sources of potentially relevant GDM biomarkers.  miR-146a-5p and miR-21-5p were quantified by real-time polymerase chain reaction in peripheral blood mononuclear cells of patients with GDM and normoglycaemic pregnant controls (n=40 each), as well as in paired samples of extracellular vesicles (EVs) extracted from serum. Correlation analysis was conducted for the expression levels of tested microRNAs and the activities of glutathione reductase (GR), total superoxide dismutase (SOD), catalase (CAT), concentration of serum thiol groups and the level of Nrf2 mRNA. In both samples, tested microRNAs were upregulated in GDM group, with a more pronounced increase in expression in EVs, compared to peripheral blood mononuclear cells (PBMCs) (1.81 vs. 1.52 fold for miR-146a-5p and 1.98 vs. 1.58 fold for miR-21-5p). There was a significant positive correlation between the expression of miR-21-5p from PBMCs and Nrf2 in both GDM patients and controls, as well as a positive correlation with the activity of total SOD in GDM patients. On the other hand, miR-146a-5p from EVs demonstrated negative correlation with Nrf2 expression and the activity of total SOD. These data demonstrate the potential of (g)OS/LLI-related microRNAs miR-146a-5p and miR-21-5p to serve as indicators of GDM and the associated (g)OS-related changes.

Colorectal cancer presents a significant global health challenge, with a high mortality rate. It is the third most commonly diagnosed cancer and is therefore a major cause for concern. The development of colorectal cancer is multifaceted, involving a combination of genetic predispositions and lifestyle factors. The redox and metabolic states may influence the intricate process of colon cancer development. To gain a deeper understanding of the redox-metabolic profiles associated with colon cancer, a human study was conducted. In biopsies from patients with colon cancer, the antioxidant status: copper, zinc superoxide dismutase (CuZnSOD), manganese superoxide dismutase (MnSOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutamate-cysteine ligase (GCL), thioredoxin (Trx) and lactate metabolism were examined in tumor and unaffected colon tissue (remote 15-20 cm) as well as in adipose tissue: proximal (near the tumour tissue), distal (remote 6 cm) and unaffected (remote over 6 cm). The protein levels of CuZnSOD, MnSOD, GSH-Px, and Trx are increased in the tumor tissue compared to the unaffected colon tissue. In addition, the expression of the lactate dehydrogenase (LDH) A isoform, the total activity of LDH and the lactate concentration are higher in transformed tumor tissue than in normal colon tissue. On the other hand, lactate concentration increases and several AD components (CuZnSOD, MnSOD, CAT, GSH-Px, GCL and Trx) decrease in adipose tissue with tumor proximity. Shifts in redox and lactate metabolism in tumor tissue associated with spatial changes in lactate and antioxidant enzymes gradients in adjacent adipose tissue clearly indicate a local redox metabolic interaction between tumor and tumor-associated adipose tissue in shaping the malignant phenotype in human colorectal cancer.

One of the adaptive features that organisms developed throughout their long natural history is the ability to change the activity of cells, tissues, and organs on a daily, 24-hour, basis. These cyclical changes are synchronized to the external environment through a light-dark regime and internal circadian clock. Daily recurring environmental changes are followed by variations in animal behavior and physiology, which include oscillations in neuroendocrine, metabolic, cardiovascular, and immune functions. By transforming the circadian periodicity of day, artificial light from anthropogenic sources might interfere with organisms leading to a disturbance in hormone levels and physiological stress. In this study, we investigated daily natural variations in the antioxidant system and the effects of artificial light on the redox balance in larvae of tree frogs. We compared antioxidant parameters in tadpoles from the natural day/night cycle (control) with ones exposed to artificial light at night (treatment). The antioxidant response was measured at four time points during 24h (morning, day, evening, and night). Our results showed that only GR activity did not display day/night changes nor was affected by night illumination. For GSH-Px and GST we reported changes in activity at different times of day that were in the same manner for both treatment and control. The highest values were in the morning compared to the other time points. Variation during 24h was also observed for SOD, CAT and GSH. However, exposure to night light affected the pattern and intensity of these parameters compared to the control group. Overall our study suggests that daily differences in metabolic activity can result in variations in the antioxidant system and that the presence of artificial light affects these changes. The disrupted natural rhythm of the antioxidant response may further reflect on other physiological processes and lead to a state of oxidative stress.

According to global epidemiology, non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting about a quarter of the adult population worldwide. NAFLD is characterised by the accumulation of triglycerides in hepatocytes (steatosis), which can progress to non-alcoholic steatohepatitis, a more severe form of NAFLD. Oxidative stress is closely linked to the disease progression due to the activation of inflammatory pathways. The aim of this study was to identify markers of redox status that could predict the risk of developing steatosis. The study included 179 participants who underwent ultrasound examination at University Medical Centers Zemun and Zvezdara. Participants were divided into two groups: 119 patients with steatosis and 60 apparently healthy controls (control group, CG). Biochemical markers as well as markers of redox status: total oxidant status (TOS) and total antioxidant status (TAS) were determined in serum spectrophotometrically on biochemical analysers. Univariate and multivariate binary logistic regression analyses were used to test the predictions of TOS and TAS for NAFLD. Patients had higher body mass index (P<0.001), glucose (P<0.001), uric acid (P<0.001), TOS (P=0.007), and TAS (P<0.001) levels compared to CG. Univariate binary regression analysis revealed significant predictive capability of TOS and TAS for NAFLD demonstrated by the following ORs: 1.104 (1.020-1.195) (P=0.014) and 1.003 (1.001-1.004) (P<0.001), respectively. After applying multivariate binary logistic regression analyses (adjustments were made for sex and BMI), TOS and TAS kept independent significant predictive capability for NAFLD, as demonstrated by the following ORs: 1.098 (1.009-1.195) (P=0.030) and 1.002 (1.000-1.003) (P=0.026), respectively. TOS and TAS are positively associated with the risk of developing NAFLD, independent of sex and BMI. Both markers are elevated, probably because increased oxidative activity requires a stronger antioxidant defence response, which should be confirmed by a follow-up study including more participants.

Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease of the central nervous system (CNS). Relapsing-remitting multiple sclerosis (RRMS) is the most common clinical subtype of MS. MS is characterized by demyelination and myelin is mainly composed of lipids. Lipids play many roles in the CNS including signaling, structural support, mediating inflammation, and membrane biogenesis. Omega-3 polyunsaturated fatty acids (PUFA) are central to maintaining health and they are present in a wide array of tissues with broad functions including the active component of phospholipid cell membranes and substrate for molecular signaling pathways. This study aimed to evaluate fatty acids (FA) profiles of patients with RRMS (n=30) compared to healthy people (n=20). Analysis of total lipids was performed from erythrocyte samples. The total lipid extracts from erythrocytes were prepared by adding chloroform/methanol (2:1, v/v) mixture containing butylated hydroxytoluene (0.05% BHT weight/volume). FA methyl esters were prepared by transmethylation with 3N HCl in methanol. FA profiles were determined by gas chromatography (GC). The content of individual FA was expressed as a percentage of the total FA. Results of this study revealed that total saturated fatty acids (SFA) are significantly higher in MS patients compared to controls. While total PUFAs, total n-3 PUFAs, and omega-3 index are statistically lower in MS patients. The n-6/n-3 ratio is significantly higher in MS patients compared to controls. Also, the AA/EPA ratio is significantly lower in the control group compared to MS patients. Conversely, the EPA/AA index is significantly reduced in MS patients. Omega-3 lipids, which have a protective role by preserving the blood-brain barrier, are significantly reduced in the erythrocytes of patients with MS. Increased n-3 PUFA and decreased SFA intake could counteract inflammation, energy storage and utilization imbalance and, overall state in patients with MS.